With reference to intimation dated May 27, 2026, the Company has completed the acqusition of Lifesenz Cancer Labs Private Limited and has become subsidiary of the Company w.e.f. June 01, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hemant Surgical Industries Ltd has completed the acquisition of Lifesenz Cancer Research Labs Private Limited, a Mumbai-based cancer research and diagnostics company. The deal was first announced on May 27, 2026, and has now been formally closed on June 01, 2026. With this completion, Lifesenz Cancer Research Labs has become a subsidiary of Hemant Surgical Industries. The filing does not disclose the deal value, share-swap ratio, or stake percentage acquired.
This expands Hemant Surgical's presence into the cancer diagnostics and research space, potentially diversifying its revenue streams. Without deal financials, investors may await further disclosures to gauge the impact on earnings and balance sheet.